TY  - CONF
  - Fitzgerald, P., Harris, D.M., Crotty, S., Harkin, A., Mandel, A., Bolton, A.E., Sullivan, A.M., Nolan, Y.
  - Society for Neuroscience meeting, Washington, USA.
  - Treatment with a novel phospholipid-based drug formulation inhibits 6-hydroxydopamine-induced p38 activation in rat substantia nigra.
  - Washington DC, USA
  - Invited Lectures (Conference)
  - 2005
  - ()
  - 1
  - 11-DEC-05
  - 16-NOV-05
  - Vasogen Ireland Limited
DA  - 2005/NaN
ER  - 

@unpublished{V379681,
   = {Fitzgerald,  P. and  Harris,  D.M. and  Crotty,  S. and  Harkin,  A. and  Mandel,  A. and  Bolton,  A.E. and  Sullivan,  A.M. and  Nolan,  Y. },
   = {Society for Neuroscience meeting, Washington, USA.},
   = {{Treatment with a novel phospholipid-based drug formulation inhibits 6-hydroxydopamine-induced p38 activation in rat substantia nigra.}},
   = {Washington DC, USA},
   = {Invited Lectures (Conference)},
   = {2005},
   = {()},
   = {1},
  month = {Dec},
   = {16-NOV-05},
   = {Vasogen Ireland Limited},
  source = {IRIS}
}